Tery Baskin

UAMS’ conflict-of-interest policy allowed it to enter into a contract that didn’t pass the smell test of anyone who didn’t have a direct interest in it and left the state’s medical school vulnerable to lost revenue. read more >

The University of Arkansas for Medical Sciences has corrected a contract that for nearly eight years gave a private company the exclusive right to market UAMS’ intellectual property and resulted in no royalty payments for UAMS. read more >

The University of Arkansas for Medical Sciences BioVentures was launched more than a decade ago to combine research at UAMS with entrepreneurship, technology licensing and economic development. BioVentures has since spun off 22 companies using technologies developed at the campus. read more >

RxResults, a pharmacy risk management company that is partly owned by the University of Arkansas for Medical Sciences, said it plans to add between 20 and 30 jobs in the next 21 months, according to a UAMS news release. Founded in 2008, RxResults was created to help lower drug costs for employers and their workers while making sure they receive the best medicines available. read more >

UAMS startup RxResults, a pharmacy risk management company based in Little Rock, on Wednesday announced a $4 million investment by Ansley Equity Partners and Ansley Equities of Naperville, Ill. read more >